24 Patents
- US124922262025Materials and Methods for Producing Bioengineered Virus Specific Lymphocytes
JANSSEN BIOTECH, Inc.
0 cites - US124922562025Methods and Compositions for Modulating Beta Chain Mediated Immunity
JANSSEN BIOTECH, Inc.
0 cites - 0 cites
- 0 cites
- US122214872025Nucleic Acids Encoding Cx3cr1-binding Polypeptides Comprising Immunoglobulin Single Variable Domains
Ablynx N.V.
0 cites - 0 cites
- US121346582024Materials and Methods for Multidirectional Biotransportation in Virotherapeutics
JANSSEN BIOTECH, Inc.
0 cites - 0 cites
- 0 cites
- US120764132024Compositions and Methods for Modulating Delta Gamma Chain Mediated Immunity
JANSSEN BIOTECH, Inc.
0 cites - US120775852024Proteins Comprising Kallikrein Related Peptidase 2 Antigen Binding Domains and Their Uses
Janssen Biotech, Inc.
0 cites - 0 cites
- US120714662024Anti-human Kallikrein-2 (hk2) Chimeric Antigen Receptor (CAR) and Methods of Use Thereof
Janssen Biotech, Inc.
0 cites - US119819322024Materials and Methods for the Manufacture of Pluripotent Stem Cells
JANSSEN BIOTECH, Inc.
0 cites - US119650242024Methods and Compositions for Modulating Beta Chain Mediated Immunity
Janssen Biotech, Inc.
0 cites - US119266672024Bioengineered T Cell Mediated Immunity, Materials and Other Methods for Modulating Cluster of Differentiation IV And/or VIII
Janssen Biotech, Inc.
0 cites - 0 cites
- US118847442024Compound Targeting IL-23A and B-cell Activating Factor (BAFF) and Uses Thereof
Macrogenics, Inc.
0 cites - US118664992024Monospecific and Multispecific Anti-tmeff2 Antibodies and Their Uses
Janssen Biotech, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites